Prophylaxis of antipsychotic-induced extrapyramidal side effects in east Indians: Cultural practice or biological necessity?

Journal of Psychiatric Practice

Volumn 10, Issue 3, 2004, Pages 200-202

  Dhavale, Hemangee S ^a   Pinto, Charles ^a   Dass, Jyoti ^a   Nayak, Ajita ^a   Kedare, Jhanavi ^a   Kamat, Manisha ^a   Dewan, Mantosh ^b,c  

^a BYL NAIR CHARITABLE HOSPITAL   (India)

^b SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^c State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

Antipsychotics; East Indians; Extrapyramidal side effects; Prophylaxis

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; COG WHEEL PHENOMENON; HALOPERIDOL; NEUROLEPTIC AGENT; UNCLASSIFIED DRUG;

ACUTE DISEASE; ACUTE DYSTONIC REACTION; ADULT; ARTICLE; CULTURAL FACTOR; DRUG EFFECT; DRUG INDUCED DISEASE; DRUG RESPONSE; DYSTONIA; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; HYPERSALIVATION; INDIA; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PROPHYLAXIS; PSYCHOSIS; RATING SCALE; RIGIDITY; SIDE EFFECT; SIMPSON ANGUS SCALE; TREMOR; WORLD HEALTH ORGANIZATION;

ADULT; ANTIPARKINSON AGENTS; ANTIPSYCHOTIC AGENTS; BASAL GANGLIA DISEASES; CULTURAL CHARACTERISTICS; FEMALE; HUMANS; INDIA; MALE; MIDDLE AGED; PSYCHOTIC DISORDERS; RISK FACTORS; SCHIZOPHRENIA;

EID: 2442667707     PISSN: 15274160     EISSN: None     Source Type: Journal    
DOI: 10.1097/00131746-200405000-00011     Document Type: Article

References (22)

1. Dewan M, Koss M. The clinical impact of the side effects of psychotropic drugs. In: Fisher S, Greenberg R. The limits of biological treatments for psychological distress. Hillsdale, NJ: Lawrence Erlbaum; 1989:189-234.
2. Keepers G, Clappison V, Casey D. Initial anticholinergic prophylaxis for neuroleptic induced extrapyramidal syndrome. Arch Gen Psychiatry 1983;40:1113-7.
3. Van Kammen D, Marder S. Dopamine receptor antagonists. In: Sadock B, Sadock V. Comprehensive textbook of psychiatry, 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2000:2356-77.
4. Van Kammen D, Marder S. Dopamine receptor antagonists. In: Kaplan H, Sadock B, eds. Comprehensive textbook of psychiatry, 6th ed. Baltimore: Williams & Wilkins: 1995:1987-2022.
5. World Health Organization (WHO). Prophylactic use of cholinergics in patients on long term neuroleptic treatment. A consensus statement. Br J Psychiatry 1989;156:412.
6. Simpson G, Angus J. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Supp 1970;4:1-9.
7. Binder R, Levy R. Extrapyramidal reactions in Asians. Am J Psychiatry 1981;138:1243-4.
8. Lehmann A, Steinwachs D. At issue: Translating research into practice: The schizophrenia patient outcomes research team (PORT) treatment recommendations. Schizophr Bull 1998;24:1-20.
9. Lin K, Finder E. Neuroleptic dosage in Asians. Am J Psychiatry 1983;140:490-1.
10. Murphy H. Ethnic variations in drug responses. Transcultural Psychiatric Research 1969;6:6-23.
11. Yamamoto J, Fung D, Lo S, et al. Psychopharmacology for Asian Americans and Pacific Islanders. Psychopharmacol Bull 1079;15:29-31.
12. Pi E, Jain A, Simpson G. Review and survey of different prescribing practices in Asia. In: Shagass C, Jossiasen R, Bridger W, et al., eds. Biological psychiatry. New York: Elsevier; 1986:1536-8.
13. Sramek J, Sayles M, Simpson G. Neuroleptic dosages for Asians: Failure to replicate. Am J Psychiatry 1986;143:535-6.
14. Potkin SB, Shen Y, Pardes H, et al. Haloperidol concentrations elevated in Chinese patients. Psychiatr Res 1984;12:167-72.
15. Lin KM, Poland RE, Lau JK, et al. Haloperidol and prolactin concentrations in Asians and Caucasians. J Clin Psychopharmacol 1988;8:195-201.
16. Lin KM, Poland RE, Nuccio I, et al. A longitudinal assessment of haloperidol doses and serum concentrations in Asian and Caucasian schizophrenic patients. Am J Psychiatry 1989;146: 1307-11.
17. Juneja R, Weitkamp L, Straitil A. Further studies of the plasma alpha 1 B-glycoprotein polymorphism: Two new alleles and allele frequencies in Caucasians and in American Blacks. Human Heredity. 1988;38:267-72.
18. Zhou HH, Adedoyin A, Wilkinson GR. Differences in plasma binding of drugs between Caucasians and Chinese subjects. Clin Pharmacol Ther 1990;48:10-7.
19. Janicak PG, Davis JM, Preskorn SH, et al. Principles and practice of psychopharmacotherapy. Baltimore: Williams & Wilkins; 1993.
20. Bjorntorp P. Obesity. Lancet 1997;350:423-6.
21. Kalow W. Race and therapeutic drug response. N Engl J Med 320:588-9.
22. Lin K-M, Anderson D, Poland RE. Ethnicity and psychopharmacology: Bridging the gap. Psychiatr Clin North Am 1995;18:635-47.